Posterior Fossa Ependymal Tumor clinical trials at UCSF
1 research study open to eligible people
Showing trials for
Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
open to eligible people ages 1-39
This is a multi-site study of the pharmacodynamic effects and efficacy of metformin in children and young adults with recurrent or progressive Posterior Fossa Group A (PFA) ependymoma.
San Francisco, California
Our lead scientists for Posterior Fossa Ependymal Tumor research studies include Sabine Mueller, MD, PhD.
Last updated: